Recombinant FCGRT (Rozanolixizumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA, WB
Hôte: Humanized
Chimeric
unconjugated
Recombinant Antibody
-
- Antigène
- FCGRT (Rozanolixizumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
- Hôte
-
Humanized
- Expression System
- Mammalian cells
- Clonalité
- Chimeric
- Application
- ELISA, Western Blotting (WB)
- Fonction
- Rozanolixizumab Biosimilar - Anti-FCGRT mAb - Research Grade
- Attributs du produit
- Antibody Type: IgG4-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Pureté
- > 85%
- Classe de qualité
- Research Grade
- Isotype
- IgG4
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- FCGRT (Rozanolixizumab Biosimilar)
- Classe de substances
- Biosimilar
- Sujet
- Rozanolixizumab, a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases.
- Numéro CAS
- 1584645-37-3
-
Vous êtes ici:
